Ontology highlight
ABSTRACT:
SUBMITTER: Lebert JM
PROVIDER: S-EPMC6001760 | biostudies-literature | 2018 Jun
REPOSITORIES: biostudies-literature
Lebert J M JM Lester R R Powell E E Seal M M McCarthy J J
Current oncology (Toronto, Ont.) 20180613 Suppl 1
Triple-negative breast cancer constitutes a heterogeneous group of malignancies that are often aggressive and associated with a poor prognosis. Molecular characterization, while not a standard of care, can further subtype triple-negative breast cancer and provide insight into prognostication and behaviour. Optimal chemotherapy regimens have yet to be established; however, there have been advances in the systemic treatment of triple-negative breast cancer in the neoadjuvant, adjuvant, and metasta ...[more]